Gastric neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male or female aged 18 or above; 2) Further gastroscopy is needed to identify the characteristics of digestive tract diseases; 3) Sedated gastroscopy; 4) Able to read, understand and sign the informed consent; 5) The investigator believes that the subject is able to understand the procedures of the clinical study and is willing and able to complete all study procedures and follow-up visits and to cooperate with the study procedures.
Exclusion criteria
Exclusion criteria: 1) Has participated in other clinical trials, signed informed consent, and is in the follow-up period of other clinical trials; 2) Has participated in a drug clinical trial and is in the washout period of the experimental or control group; 3) Has drug abuse, alcohol abuse, or mental disorder in the last 5 years; 4) Pregnant or lactating women; 5) Subjects who have had previous gastric surgery or have been diagnosed with residual stomach; 6) Subjects with biopsy contraindications; 7) Subjects with known active upper gastrointestinal bleeding or under emergency gastroscopy; 8) Subjects who, in the opinion of the investigator, are not suitable for sedated gastroscopy; 9) Subject who were not eligible for sedated gastroscopy as assessed by the anesthesiologist; 10) Subjects with medical conditions or other special situations that make the subjects unsuitable for the clinical trial in the opinion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy;sensitivity;specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| PPV;NPV; | — |
Countries
China
Contacts
Department of Gastroenterology, Renmin Hospital, Wuhan University